Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors (ENERGY)

Clinical Trial ID NCT00928889

Rank	Title	Journal	Year	PubWeight™‹?›
1	Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes.	Acta Pharmacol Sin	2007	0.78